688117 聖諾生物
按盤價 
38.990 +0.470 (+1.220%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.308 | 5.564 | 8.243 | 8.001 | 10.019 |
| 總資產報酬率 ROA (%) | 5.227 | 3.376 | 5.804 | 6.247 | 7.906 |
| 投入資產回報率 ROIC (%) | 5.829 | 3.796 | 6.684 | 7.241 | 9.527 | 邊際利潤分析 |
| 銷售毛利率 (%) | 56.886 | 57.966 | 63.761 | 65.470 | 71.973 |
| 營業利潤率 (%) | 30.867 | 13.608 | 18.643 | 18.407 | 19.613 |
| 息稅前利潤/營業總收入 (%) | 32.241 | 15.504 | 19.547 | 17.896 | 17.758 |
| 淨利潤/營業總收入 (%) | 26.341 | 10.927 | 16.166 | 16.296 | 15.847 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.879 | 119.302 | 96.783 | 101.844 | 98.751 |
| 價值變動淨收益/利潤總額(%) | 1.260 | 3.045 | -1.774 | 3.407 | 2.078 |
| 營業外收支淨額/利潤總額(%) | -1.443 | -0.897 | -1.223 | -0.659 | -7.551 | 償債能力分析 |
| 流動比率 (X) | 1.308 | 1.322 | 2.525 | 2.960 | 4.013 |
| 速動比率 (X) | 0.786 | 0.761 | 1.720 | 2.358 | 3.389 |
| 資產負債率 (%) | 43.446 | 44.273 | 33.109 | 25.385 | 17.926 |
| 帶息債務/全部投入資本 (%) | 35.496 | 37.644 | 23.452 | 11.966 | 4.619 |
| 股東權益/帶息債務 (%) | 177.890 | 164.911 | 324.497 | 728.473 | 2,041.479 |
| 股東權益/負債合計 (%) | 130.172 | 125.873 | 201.990 | 293.929 | 457.857 |
| 利息保障倍數 (X) | 17.781 | 7.684 | 17.315 | -45.787 | -37.140 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.996 | 82.643 | 86.151 | 92.325 | 92.768 |
| 存貨周轉天數 (天) | 382.224 | 468.610 | 376.514 | 311.938 | 317.967 |
| 備註： | 即時報價更新時間為 22/09/2025 15:47 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
